Venice, United States
Seed Health is a pioneering company in the realm of microbiome science, aiming to transform both human and planetary health by developing innovative microbial applications. Founded in 2016 in the United States, the company has strategically aligned with leading academic researchers to advance notable breakthroughs in the field. These efforts support a versatile pipeline that includes novel therapeutics, consumer health innovations, and environmental solutions, with commercial probiotic products marketed under the brand Seed®.
In its latest financial milestone, Seed Health secured a $40.00M Series A investment in April 2021. This round was anchored by prominent investment entities such as ARTIS Ventures, Founders Fund, 8VC, The Craftory, and GISEV Family Office, underscoring strong investor confidence. The company’s innovative approach and robust collaborations position it as a leader in microbiome treatments, poised for substantial growth and impact.
